According to Blase Polite, MD, MPP, pathways are well-designed to allow personalized medicine.
Surabhi Dangi-Garimella, PhD, then asked the panelists whether clinical pathways can prevent patients from receiving more personalized care.
Blase Polite, MD, MPP, said that “personalized medicine” is another one of those tricky terms that are thrown around, but may have different definitions for everyone. In general, however, personalized medicine is about the genetic makeup of a tumor.
In this sense, pathways are beautifully suited for personalized medicine according to Dr Polite. “I can look and know that you have a mutation that makes it much more likely that you’re going to respond to drug X or drug …It sort of forces you to say have you looked for all these personalized things. Then we’ll drive you to treatment.”
Pathways allow the physician to go off-pathway when it no longer makes sense for the patient, but one should also avoid extremes. “If I am 100% on pathway, you should be worried about me. You should also be worried if I am 80% off pathway. There is some sweet spot in there that says I am taking into account clinical situations, and I’m still using the patient in front of me, the art of medicine, everything that I know about their social situation, their opinion, etc,” Dr Polite explained.
Dr Polite hopes that in using pathways responsibly, physicians will not be penalized too severely for still practicing the art of medicine.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More